An expensive new drug that can slow the progression of Alzheimer’s disease was approved by Health Canada on Friday.

While existing medications treat Alzheimer’s symptoms, lecanemab is the first drug authorized in Canada that targets the disease’s underlying cause in order to reduce the rate of cognitive and functional decline.

To read more, click on the link below:

https://www.ctvnews.ca/health/article/canada-approves-expensive-new-drug-that-can-slow-alzheimers-disease